Life sciences fund raises $25M; Early use of antivirals clears HIV in toddler;

@FierceBiotech: ICYMI yesterday: The top 10 biotech IPOs of 2013. Special report | Follow @FierceBiotech

@JohnCFierce: Rigel sinks after adding another trial failure to its losing streak. News | Follow @JohnCFierce

@DamianFierce: Repros tanks as FDA scrutiny of testosterone drug pushes back NDA date. ICYMI yesterday | Follow @DamianFierce

@EmilyMFierce: ICYMI: Takeda, Hopkins developing new pancreatic cancer drugs. More from FierceBiotech Research | Follow @EmilyMFierce

> Austin-based PTV Sciences has raised $24.7 million. The VC group invests in life sciences companies, including molecular diagnostics company Asuragen. Story

Medical Device News

@FierceMedDev: UPDATED: Boston Scientific to slash up to 1,500 more jobs even as Q3 numbers improve. Story | Follow @FierceMedDev

@MarkHFierce: Check out this week's FierceDiagnostics newsletter | Follow @MarkHFierce

@MichaelGFierce: Layered nanoparticles deliver RNA, chemo for one-two punch. Item from FierceDrugDelivery | Follow @MichaelGFierce

> Med tech VC Versant raising $250M new fund amid sluggish market. Story

> Vitamin B2 may help build a safer 3-D medical implant. Item

> Zimmer lowers outlook as profits slide despite ortho growth. Report

> DeCODE spinout raises $15M to bring gene sequencing into daily Dx. Article

Pharma News

@FiercePharma: Roche is putting $900M into biologics manufacturing, but turning to Samsung for some of its drugs. News | Follow @FiercePharma

@CarlyHFierce: Here's FiercePharmaManufacturing's take on McKesson's Celesio buyout. More | Follow @CarlyHFierce

> GlaxoSmithKline saves $431M moving retirees to private healthcare exchanges. Article

> Teva ex-chairman: Execs should share layoffs pain with 10% pay cut. Story

Pharma Manufacturing News

@EricPFierce: Samsung, which has worked on a biosimilar of Rituxan, has a new deal to make biologics for Roche. Article | Follow @EricPFierce

> Stolen Novo growth hormone sold on Internet. Item

> McKesson makes $8.3B move on Europe. Story

> Actis invests $48M in API maker Symbiotec. News

> Hospira unveils new quality lab at troubled plant. More

Vaccines News

> Finnish team talks up prospects of Type 1 diabetes vaccine. Report

> Study finds herd immunity protects babies against whooping cough. More

> Meta-analysis links flu vaccine to lower risk of heart attack and stroke. Article

> Timing of first measles vaccine dose linked to effectiveness. Item

> Taliban anti-vaccine push raises risk of polio outbreak. Story

And Finally... Aggressive and early use of antivirals in a child has cleared HIV from his body for 18 months, suggesting that the same approach could work for other infants. Release

Suggested Articles

EQRx is adding a pair of PD-1/PD-L1 meds to its pipeline through a deal with CStone worth $150 million upfront but could net the latter $1.15 billion.

All eyes are on Pfizer’s COVID-19 vaccine work, but the Big Pharma has today quietly culled two midstage trials and one phase 1 test.

All subjects had lower extremity weakness after receiving antisense oligonucleotide GTX-102, leading Ultragenyx to pause the study.